Light Therapy in Parkinson's Disease
Recruiting · NCT06129942 · Interventional (participants receive a specific treatment) · Lead sponsor: Second Affiliated Hospital of Soochow University
View the official record on ClinicalTrials.gov →Interventions studied
Bright light boxDim Light box
What this trial is about
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
Who can take part
Age range
50 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3.
- All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period.
Exclusion criteria
- Using hypnotic or stimulating drugs.
- Using antidepressants, except stable drugs maintained for more than three months;
- Visual impairment, such as cataract, glaucoma, blindness, etc;
- Cognitive impairment (MMSE \< 24);
- There are uncontrollable hallucinations and mental diseases;
- There are sleep phase delay / advance syndrome, shift work, jet lag, etc
Where it is running
1 location listed.
- Department of Neurology, Second Affiliated Hospital of Soochow University - Suzhou, Jiangsu, China